Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2025 05:08 ET | Source: Research and Markets

Hormone Sensitive Advanced Prostate Cancer Research Report 2025-2035: PSA Screening, Genomic Profiling and Combination Therapies Drive Shift to Personalized Treatment

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Hormone Sensitive Advanced Prostate Cancer Market - A Global and Regional Analysis: Focus on Drug Class, Treatment, and Region - Analysis and...
September 17, 2025 02:55 ET | Source: Hofseth Biocare ASA

Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.5M AT A $30M VALUATION FOR ONGOING FT-002A PEPTIDE DEVELOPMENT IN PROSTATE CANCER

AecorBio Inc., formerly known as HBC Immunology Inc, has successfully completed a further equity financing round of $1.5m from existing and new investors at a company valuation of $30 million. This...
August 11, 2025 05:13 ET | Source: Research and Markets

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations

Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Non-metastatic Prostate Cancer Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been...
July 25, 2025 10:40 ET | Source: Research and Markets

Metastatic Hormone Refractory Prostate Cancer Pipeline Market Research Report 2025 | In-depth Analysis of 180+ Companies and Over 200 Drugs in Development

Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Metastatic Hormone...
October 24, 2024 04:27 ET | Source: Research and Markets

Understand the United States Prostate Cancer Patient Experience in 2023: Demographics, Impact on Quality of Life, Information-seeking Behaviors, HCP Engagement, Treatment Awareness and Experiences

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Prostate Cancer in the United States: Understanding the Prostate Cancer Patient Experience" report has been added to ResearchAndMarkets.com's...
June 28, 2024 10:17 ET | Source: Research and Markets

Metastatic Castration-Resistant Prostate Cancer in Major Global Markets, 2024-2034: Drug Sales, Epidemiology Forecast, Trends, Unmet Needs, and More

Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Castration-Resistant Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report...
April 24, 2024 16:02 ET | Source: FibroGen, Inc.

FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology Annual Meeting

SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that clinical data from the dose escalation portion of the Phase 1b/2 study of FG-3246 in combination...
January 24, 2024 10:39 ET | Source: Research and Markets

Non-metastatic Prostate Cancer (nmPC) Market, Epidemiology, and Forecast - Strategic Insight until 2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's...
January 22, 2024 16:58 ET | Source: Research and Markets

Prostate Cancer Drugs Global Market Report 2024: Emerging Combination Therapies and Geographic Expansion to Propel the Global Prostate Cancer Drugs Market Through 2028

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Prostate Cancer Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This recent comprehensive study sheds...
January 04, 2024 18:33 ET | Source: Research and Markets

Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032

Dublin, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This...